Focus. Together. For patients and society.
ABOUT IPSEN
Our team of over 5,000 talented and dedicated professionals around the world works together every day to innovate for the benefit of people living with a rare disease, cancer or a neurological condition and their caregivers.
Making an impact
Our passion drives our commitment to individuals living with difficult-to-treat diseases — and we put them first and help through our expertise in oncology, neuroscience, and rare disease. Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation.
Download our annual report
Leading the way
With a talented team of over 90 people, our Canadian operation brings together the best of both worlds: the agility of a start-up, backed by the resources and experience of a global biopharmaceutical company. Our Canadian headquarters is located in Mississauga, Ontario and is a member of Innovative Medicines Canada (IMC).
I’m very proud of the team and community that we’ve built at Ipsen in Canada. Our focus is clear. We are inspired by our purpose of bringing our innovative medicines to Canadian patients.
Our strategy
Our strategy, Focus. Together. For patients & society, consists of four strategic priorities that guide our decision-making.
We are focused on ensuring patients have access to our treatments, collaborating with them and with patient organizations to unlock key insights that will allow us to deliver advancements. We work tirelessly to ensure patients have access to our innovative treatments.
We’re committed to building a robust, sustainable pipeline across all stages of development and in each of our three therapy areas so that we can continue to deliver innovative treatments, now and in the future. We seek out biotechs, academic institutions and other partners who share our vision of making a real impact for patients, and we aim to deliver at least one molecular entity or meaningful indication every year.
We focus our efforts and resources where they will move the needle for patients. By creating efficiencies, we can make the right investments at the right time to bring new, innovative therapies to patients around the world.
Our team of over 5,000 talented and dedicated professionals around the world endeavors every day to develop and build our capabilities. With our science-led and patient-driven approach, we grow together in a supportive environment.
Our ESG commitment
Our mission is clear: to prolong and improve patients’ lives and health outcomes and make a positive impact for society. Our ESG framework guides us as we deliver positive change across four key areas: Environment, Patients, People and Governance.
Learn moreOur global presence
Ipsen’s products are registered in more than 100 countries. With 5,000 employees working to create value for patients and society around the world, we have global reach while remaining an agile, mid-sized company.
FONDATION IPSEN
Rare but not alone
Functioning independently of Ipsen, Fondation Ipsen is dedicated to increasing scientific knowledge and patient research. Focused on improving the lives of patients with rare diseases, Fondation Ipsen improves understanding of rare diseases through information-sharing and strategic partnerships with key actors in the rare disease community.
Find out more about Fondation Ipsen